Lapatinib Completed Phase 3 Trials for Neoplasms, Head and Neck Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00424255Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery